Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients

Clinical trial NCT05944458 · COMPLETED

Trial details

NCT number: NCT05944458
Sponsor: Helwan University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Linezolid Antioxidant Thrombocytopenia Critical Illness ICU

Start date: 2023-08-01
Primary completion: 2025-06-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.